...
search icon
nerv-img

Minerva Neurosciences Inc Share Price

NERV
NAQ
$6.01
+$0.07
(1.18%)
1D
Industry: Biotechnology Sector: Health Care

Minerva Neurosciences Inc Analyst Forecast

Minerva Neurosciences Inc Share Price Chart

Minerva Neurosciences Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$257.05M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
86.66K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.42
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.15 L
$7.19 H
$6.01

About Minerva Neurosciences Inc, Common Stock

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of negative symptoms in patients with schizophrenia. The company also has exclusive rights to develop and commercialize MIN-301, a soluble recombinant form of the Neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts. more

Industry: BiotechnologySector: Health Care

Minerva Neurosciences Inc Stock Returns

Time FrameNERVSectorS&P500
1-Week Return-8.94%-3.93%-0.67%
1-Month Return25.21%-2.41%-1.33%
3-Month Return55.3%1.64%-0.29%
6-Month Return176.96%11.65%5.08%
1-Year Return262.05%3.11%19.01%
3-Year Return190.34%19.21%68.62%
5-Year Return-76.45%36.52%78.6%
10-Year Return-85.77%126.5%240.69%

Minerva Neurosciences Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue41.18M----[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue176.18K101.79K8.51K30.98K22.47K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":57.77,"profit":true},{"date":"2022-12-31","value":4.83,"profit":true},{"date":"2023-12-31","value":17.59,"profit":true},{"date":"2024-12-31","value":12.75,"profit":true}]
Gross Profit41.18M(102.00K)(8.51K)(30.98K)(22.47K)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-0.25,"profit":false},{"date":"2022-12-31","value":-0.02,"profit":false},{"date":"2023-12-31","value":-0.08,"profit":false},{"date":"2024-12-31","value":-0.05,"profit":false}]
Gross Margin100.00%(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]
Operating Expenses39.33M45.37M25.23M23.12M21.85M[{"date":"2020-12-31","value":86.69,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":55.62,"profit":true},{"date":"2023-12-31","value":50.96,"profit":true},{"date":"2024-12-31","value":48.16,"profit":true}]
Operating Income1.85M(45.37M)(25.23M)(23.12M)(21.85M)[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-2456.18,"profit":false},{"date":"2022-12-31","value":-1366.07,"profit":false},{"date":"2023-12-31","value":-1251.74,"profit":false},{"date":"2024-12-31","value":-1182.91,"profit":false}]
Total Non-Operating Income/Expense94.02K(12.67M)(14.28M)(14.90M)18.73M[{"date":"2020-12-31","value":0.5,"profit":true},{"date":"2021-12-31","value":-67.67,"profit":false},{"date":"2022-12-31","value":-76.28,"profit":false},{"date":"2023-12-31","value":-79.6,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income1.94M(51.71M)(32.11M)(30.01M)1.44M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-2664.06,"profit":false},{"date":"2022-12-31","value":-1654.23,"profit":false},{"date":"2023-12-31","value":-1545.87,"profit":false},{"date":"2024-12-31","value":74.13,"profit":true}]
Income Taxes(94.02K)(1.80M)6.88M(2.00)-[{"date":"2020-12-31","value":-1.37,"profit":false},{"date":"2021-12-31","value":-26.22,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes2.04M(49.91M)(38.99M)(30.01M)-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-2452.35,"profit":false},{"date":"2022-12-31","value":-1915.74,"profit":false},{"date":"2023-12-31","value":-1474.45,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations1.94M(49.91M)(32.11M)(27.71M)1.44M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-2571.45,"profit":false},{"date":"2022-12-31","value":-1654.43,"profit":false},{"date":"2023-12-31","value":-1427.73,"profit":false},{"date":"2024-12-31","value":74.14,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income1.94M(49.91M)(32.11M)(30.01M)1.44M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-2571.15,"profit":false},{"date":"2022-12-31","value":-1654.23,"profit":false},{"date":"2023-12-31","value":-1545.87,"profit":false},{"date":"2024-12-31","value":74.13,"profit":true}]
EPS (Diluted)0.40(9.20)(6.02)(4.85)0.19[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-2300,"profit":false},{"date":"2022-12-31","value":-1505,"profit":false},{"date":"2023-12-31","value":-1212.5,"profit":false},{"date":"2024-12-31","value":47.5,"profit":true}]

Minerva Neurosciences Inc Ratios

Minerva Neurosciences Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

NERV
Cash Ratio 4.60
Current Ratio 4.87

Minerva Neurosciences Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NERV
ROA (LTM) -25.82%
ROE (LTM) -675.09%

Minerva Neurosciences Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NERV
Debt Ratio Lower is generally better. Negative is bad. 2.23
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -1.23

Minerva Neurosciences Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NERV
Trailing PE NM
Forward PE 11.21
P/S (TTM) 1.87
P/B 2.68
Price/FCF NM
EV/R 0.03
EV/Ebitda 1.01
PEG NM

FAQs

What is Minerva Neurosciences Inc share price today?

Minerva Neurosciences Inc (NERV) share price today is $6.01

Can Indians buy Minerva Neurosciences Inc shares?

Yes, Indians can buy shares of Minerva Neurosciences Inc (NERV) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NERV stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Minerva Neurosciences Inc be purchased?

Yes, you can purchase fractional shares of Minerva Neurosciences Inc (NERV) via the Vested app. You can start investing in Minerva Neurosciences Inc (NERV) with a minimum investment of $1.

How to invest in Minerva Neurosciences Inc shares from India?

You can invest in shares of Minerva Neurosciences Inc (NERV) via Vested in three simple steps:

  • Click on Sign Up or Invest in NERV stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Minerva Neurosciences Inc shares
What is Minerva Neurosciences Inc 52-week high and low stock price?

The 52-week high price of Minerva Neurosciences Inc (NERV) is $7.19. The 52-week low price of Minerva Neurosciences Inc (NERV) is $1.15.

What is Minerva Neurosciences Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Minerva Neurosciences Inc (NERV) is

What is Minerva Neurosciences Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Minerva Neurosciences Inc (NERV) is 2.68

What is Minerva Neurosciences Inc dividend yield?

The dividend yield of Minerva Neurosciences Inc (NERV) is 0.00%

What is the Market Cap of Minerva Neurosciences Inc?

The market capitalization of Minerva Neurosciences Inc (NERV) is $257.05M

What is Minerva Neurosciences Inc's stock symbol?

The stock symbol (or ticker) of Minerva Neurosciences Inc is NERV

How Can Investors Use Minerva Neurosciences Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Minerva Neurosciences Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Minerva Neurosciences Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Minerva Neurosciences Inc shares for Indian investors?

When investing in Minerva Neurosciences Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Minerva Neurosciences Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Minerva Neurosciences Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Minerva Neurosciences Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Minerva Neurosciences Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top